AnalystsDaniel StauderDaniel Stauder's Stock Forecasts
AnalystsDaniel Stauder
Analyst Ranking
Top 35%
#1729 out of 4929 analysts
Average Return
+4.12%
Win Rate
56%9 out of 16
Risk vs Reward
Poor
Good
Daniel Stauder's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Lemaitre Vascular IncLMAT | +80.09% | $48.46 | $87.27 | 2023-10-23 - 2024-10-22 | Buy |
Axon Enterprise IncAXON | +38.97% | $572.40 | $795.48 | 2025-02-26 - 2025-07-03 | Buy |
Artivion IncAORT | +20.19% | $25.56 | $30.72 | 2025-02-25 - 2025-07-03 | Buy |
Artivion IncAORT | +14.37% | $26.86 | $30.72 | 2024-10-23 - 2025-07-03 | Buy |
Artivion IncAORT | +12.04% | $27.42 | $30.72 | 2025-05-06 - 2025-07-03 | Buy |
Daniel Stauder Analyst Color
Get additional color on Daniel Stauder's coverage of popular stocks
Daniel Stauder's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Artivion IncAORT | 4 | Buy | $33.00 | +7.42% | Reiterates | 2 months ago |
Atricure IncATRC | 6 | Buy | $60.00 | +88.92% | Reiterates | 2 months ago |
Neuronetics IncSTIM | 1 | Buy | $7.00 | +105.88% | Maintains | 4 months ago |
Lemaitre Vascular IncLMAT | 4 | Strong Buy | $110.00 | +30.35% | Maintains | 4 months ago |
Axon Enterprise IncAXON | 1 | Buy | $725.00 | -8.86% | Reiterates | 4 months ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.